Zapping the brain to unlock words: new hope for Alzheimer's communication loss

NCT ID NCT04482179

Completed Symptom relief Sponsor: University of Pennsylvania Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether a combination of transcranial magnetic stimulation (TMS) and language therapy can improve verbal communication in people with mild-to-moderate Alzheimer's disease. Twenty-three participants received either real TMS or a sham (fake) version along with language therapy. The goal was to see if the real TMS boosted the effects of therapy on speech and naming ability.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Transcranial magnetic stimulation (TMS) and constraint-induced language therapy
What this could lead to: If it works, this could point toward a non-drug way to help people with Alzheimer's communicate better.
What could go wrong: This is a small, early-phase study (23 people) with no results yet. The improvement may be small or not last, and TMS can cause mild side effects like headache.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE

Contacts and locations

Show contact details

Locations

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.